Web Exclusives

How Virtual Learning Can Reduce Stress for Children with Cancer
COVID-19Pediatric Cancer
Web Exclusives – September 4, 2020
COVID-19 has brought virtual learning into the mainstream, meaning that a child with cancer who learns from home is now in the same “classroom” environment as any other student, which can reduce feelings of stress and anxiety.
Empowerment Through Exercise: How Physical Activity Benefits Patients with Cancer
Exercise & Cancer
Web Exclusives – August 21, 2020
Exercise has been shown to reduce the risk of a wide range of chronic diseases, and is beneficial during and after cancer treatment to maintain patients’ physical and emotional well-being.
Spreading a Vision of Love and Hope
Support Services
Web Exclusives – August 6, 2020
After the death of her brother from testicular cancer, Meg McQuarrie followed his life-affirming approach to cancer treatment by creating Elixir Fund, a nonprofit organization focused on helping patients with cancer and their caregivers.
July is UVC Safety Awareness Month
Skin CancerSlideshows
Web Exclusives – July 17, 2020
View this slideshow to learn how to protect yourself from harmful ultraviolet radiation.
How Patients with Cancer Can Get Treatment Back on Track as States Reopen
Web Exclusives – July 13, 2020
As states roll out their reopening plans, patients with cancer need to start scheduling treatments that have been postponed or canceled because of the COVID-19 pandemic.
Helping Others Care for You
Support ServicesSurvivorship
Web Exclusives – July 10, 2020
Mend Together: a new website connects patients with cancer with friends and family during challenging times.
Web Exclusives – June 23, 2020
Long-term results of a pivotal trial of acalabrutinib verify that it is effective and safe as first-line therapy for patients with chronic lymphocytic leukemia.
Web Exclusives – June 23, 2020
According to findings from a large clinical trial, the combination of ibrutinib and ublituximab is effective in treating patients with chronic lymphocytic leukemia.
Web Exclusives – June 23, 2020
The ASCEND trial confirmed that acalabrutinib, a next-generation targeted treatment, is more effective than traditional chemoimmunotherapy in patients with relapsed chronic lymphocytic leukemia.
Web Exclusives – June 23, 2020
Recently reported data show that fixed-duration treatment with venetoclax and obinutuzumab for 12 months is effective and tolerable in some patients with chronic lymphocytic leukemia.
Page 1 of 15
Results 1 - 10 of 142

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.